Marinus Pharmaceuticals, Inc. (MRNS)

Marinus Pharmaceuticals Revenue

Marinus Pharmaceuticals had revenue of $8.54M in the quarter ending September 30, 2024, with 16.39% growth. This brings the company's revenue in the last twelve months to $31.47M, up 1.63% year-over-year. In the year 2023, Marinus Pharmaceuticals had annual revenue of $30.99M with 21.63% growth.

• Revenue (ttm): $31.47M
• Revenue Growth: +1.63%
• P/S Ratio: 0.56
• Revenue / Employee: $189,554
• Employees: 166
• Market Cap: 17.02M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	30.99M	5.51M	21.63%
Dec 31, 2022	25.48M	10.13M	66.03%
Dec 31, 2021	15.35M	13.63M	793.19%
Dec 31, 2020	1.72M	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.